<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03471936</url>
  </required_header>
  <id_info>
    <org_study_id>RADICAL001</org_study_id>
    <nct_id>NCT03471936</nct_id>
  </id_info>
  <brief_title>Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease</brief_title>
  <acronym>RaDICAL-CHD</acronym>
  <official_title>Right Ventricular Diastolic Function in Chronic Adverse RV Loading And Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to assess the characteristics, incidence and predictors of
      load-independent right ventricle (RV) diastolic dysfunction in patients with congenital heart
      disease (CHD) and adverse RV loading conditions by acquiring pressure-volume loops and
      compare these results to a population of patients with exclusion of coronary artery disease
      and absence of any known disease affecting the RV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the major problems in the expanding population of patients with congenital heart
      disease (CHD) is dysfunction of the right ventricular (RV) outflow tract (OT). Initial
      surgical repair for complex conditions or repeated surgery for free pulmonary regurgitation
      often includes the creation of an artificial RV to main pulmonary artery connection. Over
      time, these conduits are prone to develop valvar incompetence or obstruction. There is clear
      evidence that pulmonary stenosis and pulmonary regurgitation are associated with exercise
      intolerance, arrhythmias and an increased risk of sudden death. Timely pulmonary valve
      replacement can halt and may reverse such unfavourable outcomes. However, this means that
      patients have to undergo multiple open-heart surgeries in order to reduce the haemodynamic
      burden on the right ventricle. Decision making in these patients with RVOT dysfunction is
      based on the aim to perform pulmonary valve replacement as late as possible to minimise the
      total number of open-heart surgeries required in individual patients, but before functional
      impairment might be irreversible. Importantly, this point of 'no return' in right ventricular
      pressure and/or volume overload is still unknown and represents one of the most challenging
      problems in the field of CHD. Ideally, quality of life, survival and freedom from atrial and
      ventricular arrhythmia should be the endpoints for any study trying to optimise timing of
      pulmonary valve replacement. However, such studies would require long follow-up in large
      patient populations and will not help to improve management of right ventricular outflow
      tract (RVOT) dysfunction in the short-term. In order to design studies with surrogate
      functional endpoints, a sound understanding of physiological consequences of altering RV
      loading and its implications for bi-ventricular function or exercise capacity is pivotal.

      The investigators established a method of acquiring robust RV pressure-volume-loops at our
      institution. In the context of a research study, the investigators performed RV conductance
      catheter measurements in 22 patients with heart failure with preserved ejection fraction and
      in 11 patients with no evidence of any RV disease. Within the RaDICAL study the investigators
      aim further to compare these results to pressure-volume loops acquired in patients with
      congenital heart disease (CHD) and adverse RV loading conditions in order to evaluate
      characteristics, incidence and predictors of load-independent right ventricle (RV) diastolic
      dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 7, 2016</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of RV diastolic dysfunction in CHD and RVOT dysfunction</measure>
    <time_frame>Baseline</time_frame>
    <description>Determination of load-independent stiffness constant in CHD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Link between RV load-independent stiffness constant and functional capacity</measure>
    <time_frame>Baseline</time_frame>
    <description>Oxygen uptake (VO2 max) in correlation to load-independent stiffness constant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between E/É and RV stiffness in CHD</measure>
    <time_frame>Baseline</time_frame>
    <description>Correlation between E/É and load-independent stiffness constant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between RV stiffness expressed as E/É and functional outcome after surgical or percutaneous pulmonary valve replacement</measure>
    <time_frame>6 months</time_frame>
    <description>Correlation between E/É before intervention and VO2 max change after pulmonary valve replacement</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pulmonary Regurgitation</condition>
  <condition>Congenital Heart Disease</condition>
  <arm_group>
    <arm_group_label>Acquisition of pressure-volume loops</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Acquisition of pressure-volume-loops</intervention_name>
    <description>Diagnostic workup including cardiac MRI, Echocardiography and cardiopulmonary exercise test (CPET) followed by invasive acquisition of RV and left ventricular (LV) pressure-volume-loops</description>
    <arm_group_label>Acquisition of pressure-volume loops</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with CHD involving the RV

          -  Chronic RV volume and/or pressure overload as defined by:

          -  more than mild pulmonary regurgitation and/or

          -  more than mild tricuspid regurgitation and/or

          -  a gradient across the RV outflow tract of ≥ 3 m/s on echocardiography and/or

          -  estimated RV systolic pressure &gt; 65 mmHg

          -  Clinical indication for cardiac catheterization

          -  Age 12 to 80 years

          -  Informed consent

        Exclusion Criteria:

          -  Contraindication for magnetic resonance imaging or cardiopulmonary exercise testing

          -  Pregnancy

          -  RV systolic function on magnetic resonance imaging &lt; 45%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingo Dähnert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of pediatric cardiology, Heart Center Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ingo Dähnert, MD</last_name>
    <email>ingo.daehnert@helios-kliniken.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <email>philipp.lurz@gmx.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>+49341865252022</phone>
      <email>Philipp.Lurz@gmx.de</email>
    </contact>
    <contact_backup>
      <last_name>Tobias Kister, MD</last_name>
      <phone>+49341865252536</phone>
      <email>tobias.kister@icloud.com</email>
    </contact_backup>
    <investigator>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ingo Dähnert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tobias Kister, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Wagner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Grothoff, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg. 2005 Aug;80(2):655-63; discussion 663-4.</citation>
    <PMID>16039222</PMID>
  </reference>
  <reference>
    <citation>Rastan AJ, Walther T, Daehnert I, Hambsch J, Mohr FW, Janousek J, Kostelka M. Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome. Ann Thorac Surg. 2006 Oct;82(4):1308-15.</citation>
    <PMID>16996925</PMID>
  </reference>
  <reference>
    <citation>Stark J, Bull C, Stajevic M, Jothi M, Elliott M, de Leval M. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg. 1998 Mar;115(3):506-14; discussion 514-6.</citation>
    <PMID>9535436</PMID>
  </reference>
  <reference>
    <citation>Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA, Wyman JD, Fedderly RT, Berger S, Frommelt MA, Lewis DA, Friedberg DZ, Thomas JP Jr, Sachdeva R, Litwin SB. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation. 2000 Nov 7;102(19 Suppl 3):III130-5.</citation>
    <PMID>11082375</PMID>
  </reference>
  <reference>
    <citation>Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000 Sep 16;356(9234):975-81.</citation>
    <PMID>11041398</PMID>
  </reference>
  <reference>
    <citation>Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J. 1992 Jun;67(6):470-3.</citation>
    <PMID>1622697</PMID>
  </reference>
  <reference>
    <citation>Lurz P, Puranik R, Nordmeyer J, Muthurangu V, Hansen MS, Schievano S, Marek J, Bonhoeffer P, Taylor AM. Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J. 2009 Sep;30(18):2266-74. doi: 10.1093/eurheartj/ehp258. Epub 2009 Jun 26.</citation>
    <PMID>19561027</PMID>
  </reference>
  <reference>
    <citation>Lurz P, Riede FT, Taylor AM, Wagner R, Nordmeyer J, Khambadkone S, Kinzel P, Derrick G, Schuler G, Bonhoeffer P, Giardini A, Daehnert I. Impact of percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction on exercise recovery kinetics. Int J Cardiol. 2014 Nov 15;177(1):276-80. doi: 10.1016/j.ijcard.2014.09.014. Epub 2014 Sep 22.</citation>
    <PMID>25499392</PMID>
  </reference>
  <reference>
    <citation>Lurz P, Nordmeyer J, Muthurangu V, Khambadkone S, Derrick G, Yates R, Sury M, Bonhoeffer P, Taylor AM. Comparison of bare metal stenting and percutaneous pulmonary valve implantation for treatment of right ventricular outflow tract obstruction: use of an x-ray/magnetic resonance hybrid laboratory for acute physiological assessment. Circulation. 2009 Jun 16;119(23):2995-3001. doi: 10.1161/CIRCULATIONAHA.108.836312. Epub 2009 Jun 1.</citation>
    <PMID>19487596</PMID>
  </reference>
  <reference>
    <citation>Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation. 2008 Apr 15;117(15):1964-72. doi: 10.1161/CIRCULATIONAHA.107.735779. Epub 2008 Apr 7.</citation>
    <PMID>18391109</PMID>
  </reference>
  <reference>
    <citation>Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H501-12. Review.</citation>
    <PMID>16014610</PMID>
  </reference>
  <reference>
    <citation>Dimopoulos K, Okonko DO, Diller GP, Broberg CS, Salukhe TV, Babu-Narayan SV, Li W, Uebing A, Bayne S, Wensel R, Piepoli MF, Poole-Wilson PA, Francis DP, Gatzoulis MA. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006 Jun 20;113(24):2796-802. Epub 2006 Jun 12.</citation>
    <PMID>16769913</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2018</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Clinical Investigator M.D. Ph. D. Philipp Lurz</investigator_title>
  </responsible_party>
  <keyword>Congenital Heart Disease</keyword>
  <keyword>pressure-volume loops</keyword>
  <keyword>diastolic function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

